(Q44628516)

4 December 2017

Novel risk markers and clinical practice (English)

1 reference

4 December 2017

Novel Risk Markers and Clinical Practice (English)

1 reference

24 March 2024

Teri Manolio

1

0 references

language of work or name

English

0 references

publication date

1 October 2003

1 reference

4 December 2017

23 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14573728

reference URL

full work available at URL

24 March 2024

http://www.nejm.org/doi/pdf/10.1056/NEJMp038136

1 reference

The New England Journal of Medicine

24 March 2024

published in

1 reference

4 December 2017

349

1 reference

4 December 2017

17

1 reference

4 December 2017

1587-1589

1 reference

Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy

4 December 2017

1

1 reference

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

24 March 2024

2

1 reference

Analytical and biologic variability in measures of hemostasis, fibrinolysis, and inflammation: assessment and implications for epidemiology

24 March 2024

4

1 reference

Association between myeloperoxidase levels and risk of coronary artery disease

24 March 2024

5

1 reference

Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes

24 March 2024

6

1 reference

Glutathione Peroxidase 1 Activity and Cardiovascular Events in Patients with Coronary Artery Disease

24 March 2024

7

1 reference

Prognostic value of myeloperoxidase in patients with chest pain

24 March 2024

8

1 reference

24 March 2024

Identifiers

DOI

10.1056/NEJMP038136

1 reference

4 December 2017

1 reference